Lipocine (LPCN) Return on Equity [ROE] (2013 - 2025)
Lipocine (LPCN) recorded Return on Equity [ROE] of -35.02% in Q3 2025, down 14.90 percentage points from -20.12% a year earlier and down 10.20 percentage points from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Return on Equity [ROE] (2013 - 2025) Analysis & Trends
For FY2024, Lipocine reported Return on Equity [ROE] of 0.04%, up 58.44 percentage points from FY2023.
- Annual Return on Equity [ROE] has a five-year change of +165.51 percentage points (FY2019 to FY2024).
- Across earlier years, Return on Equity [ROE] came in at -58.40% in FY2023 (-31.90 pp), -26.50% in FY2022 (-24.41 pp), -2.08% in FY2021 (+191.77 pp) and -193.85% in FY2020 (-28.38 pp).
- The Q3 2025 figure is the lowest quarterly Return on Equity [ROE] since Q2 2024.
- On a year-over-year basis, Return on Equity [ROE] rose in five of the last eight quarters, with an average year-over-year change of +9.94 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 177.95 percentage points in Q1 2021, against a drop of 74.44 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -24.81% (Q2 2025), -26.72% (Q1 2025) and 0.04% (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Lipocine | 11.92 Mn | -55.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -35.02% |
| Jun 30, 2025 | -24.81% |
| Mar 31, 2025 | -26.72% |
| Dec 31, 2024 | 0.04% |
| Sep 30, 2024 | -20.12% |
| Jun 30, 2024 | -37.59% |
| Mar 31, 2024 | -40.47% |
| Dec 31, 2023 | -76.32% |
| Sep 30, 2023 | -63.88% |
| Jun 30, 2023 | -39.85% |
| Mar 31, 2023 | -32.96% |
| Dec 31, 2022 | -29.36% |
| Sep 30, 2022 | 10.56% |
| Jun 30, 2022 | 8.32% |
| Mar 31, 2022 | -1.71% |
| Dec 31, 2021 | -1.62% |
| Sep 30, 2021 | -51.84% |
| Jun 30, 2021 | -48.64% |
| Mar 31, 2021 | -64.30% |
| Dec 31, 2020 | -140.47% |
API Access
Lipocine Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();